So far, 24 people have died of fungal meningitis after they were injected with tainted steroids made at a compounding pharmacy in Massachusetts. Another 328 people in 18 states have fallen ill.
What those patients didn’t know is that the pharmacy that made the steroids and others like it have been largely exempted from Food and Drug Administration oversight.
More FDA oversight in the specialty businesses is needed, but it should be done in a way that does not bring onerous regulation to the many small compounding pharmacies that provide a valuable service for patients and doctors.
Most of the compounding pharmacies are small operations that custom-mix drugs, such as specific compounds to treat children or seniors who can’t easily swallow pills.
The small, specialized industry didn’t come under the same regulation as large drug makers who must ensure they’re operating sterile facilities in a safe manner.
But some compounding pharmacies have grown into mega-drug manufacturers that are pushing the legal limits.
An FDA official warned in 2003 that some large compounders were using “creative marketing” to sell drugs they claimed were superior, without any evidence of support. Still others were manufacturing drugs they claimed were unique, when they were in fact simply cheaper versions of existing drugs.
Regulation of compounding pharmacies has been left to the states, with some assuming that role well while others are unprepared to provide real oversight.
Congress will need to find ways to rein in so-called compounding pharmacies that are operating in an unsafe manner. But they and the FDA must also be careful not to put needless and costly regulations on legitimate smaller operations.
The Free Press, Mankato, Minn.
Opinion
Other Views: Regulate with care
- Opinion
-
-
Our View: ‘Why?’ has no answer
Just hours before, there was breakfast and laughter. There were pictures on the walls and memories in every room.
-
Our View: Absent from House
We can’t figure out why two Missouri legislators think they should be elected to the U.S. House when it appears they can’t seem to show up to take care of business in the Missouri House.
-
Your View: Terrorism is terrorism
In the May 13 issue of The Joplin Globe there was an Associated Press article concerning the New Orleans shooting.
-
Your View: Should we be outraged?
Were there effusive apologies following the lockdown of Boston as most of the continent indulged vicariously in the ongoing manhunt?
-
Your View: Terrible injustice
I see this Jasper County nuisance law as a terrible injustice on the rights of the residents of Jasper County.
-
Other Views: Conflicts in SEC
Money talks. In the continuing dispute over the all-too-cozy relationship between the people who create and sell financial products and the people who rate their risk, the money says: Shut up and let us do what we want.
-
Phill Brooks, columnist: Missouri Senate did what Founding Fathers had in mind
George Washington once described the Senate as being like a saucer in which you pour coffee or tea.
-
Our View: Fixing failure
Some 1,200 injured workers will finally get the payments they are owed. In its final week in session, Missouri’s General Assembly, through bipartisan efforts, passed a solution to address the insolvency of the state’s Second Injury Fund.
-
Herb B. Kuhn, guest columnist: Delaying Medicaid reform could hurt rural Missouri
The Missouri Legislature missed a rare opportunity in the just-ended session to transform Medicaid and make a real difference in the lives and health of hundreds of thousands of our neighbors. Rural Missouri has the most to lose from the legislature’s failure to act.
-
Kevin Wilson, guest columnist: When fear wins out, so do the terrorists
I’m going to make a bold statement that’s sure to draw a lot of comments, but hear me out before reaching for the keyboard to type a rebuttal.
- More Opinion Headlines
-



